The American Red Cross - Biomedical Services employs a range of advanced technologies and methodologies to ensure the safety, quality, and availability of blood products. As the largest provider of blood products in the United States, the organization utilizes a comprehensive network of collection centers and donor resources to supply approximately 6.5 million blood products annually. Their commitment to innovation is evident in their adoption of leukoreduction as a standard practice, the implementation of pathogen-reduced platelet supplies, and the introduction of low titer O whole blood for trauma care. Additionally, the Red Cross actively participates in clinical trials to enhance blood safety and product development, demonstrating their leadership in transfusion medicine.

In the realm of cell and gene therapy, the American Red Cross offers specialized collection services and source materials, including leukapaks and whole blood for research purposes. Their facilities are equipped with new cleanrooms designed to uphold high standards of quality and safety, which are crucial for supporting clinical trials and commercial therapies. The organization also emphasizes the importance of diverse donor recruitment strategies, leveraging digital platforms and social media to engage various communities. This approach not only addresses the urgent need for specific blood types but also reinforces the Red Cross's role as an advocate for hospitals and patients, ensuring that blood products meet the evolving needs of modern healthcare.

United States

Red Cross Blood Services is a Hospital and Health Care company located in 78 Eastern Blvd Ste 3, Glastonbury, Connecticut, United States.

American Red Cross - Biomedical Services

Company Details